BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20434027)

  • 1. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
    Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
    J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
    Song MJ; Chae JH; Park EA; Ki CS
    J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients.
    Okita M; Nakanishi G; Fujimoto N; Shiomi M; Yamada T; Wataya-Kaneda M; Takijiri C; Yokoyama Y; Sunohara A; Tanaka T
    J Dermatol; 2013 Apr; 40(4):272-6. PubMed ID: 23398170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
    Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An incontinentia pigmenti family with deletion in both NEMO gene and pseudogene DeltaNEMO].
    Zhang G; Shi H; Du X; Shao M; Zhou Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):573-5. PubMed ID: 18841575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incontinentia pigmenti in a newborn with NEMO mutation.
    Lee Y; Kim S; Kim K; Chang M
    J Korean Med Sci; 2011 Feb; 26(2):308-11. PubMed ID: 21286028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.
    Kenwrick S; Woffendin H; Jakins T; Shuttleworth SG; Mayer E; Greenhalgh L; Whittaker J; Rugolotto S; Bardaro T; Esposito T; D'Urso M; Soli F; Turco A; Smahi A; Hamel-Teillac D; Lyonnet S; Bonnefont JP; Munnich A; Aradhya S; Kashork CD; Shaffer LG; Nelson DL; Levy M; Lewis RA;
    Am J Hum Genet; 2001 Dec; 69(6):1210-7. PubMed ID: 11673821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
    Zou CC; Zhao ZY
    Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incontinentia Pigmenti.
    Cammarata-Scalisi F; Fusco F; Ursini MV
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):273-278. PubMed ID: 30660327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of incontinentia pigmenti in Japan and its genetic examination.
    Huang J; Kondo H; Uchio E
    Jpn J Ophthalmol; 2007; 51(2):142-5. PubMed ID: 17401626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
    Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
    Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of molecular studies in incontinentia pigmenti patients.
    Thakur S; Puri RD; Kohli S; Saxena R; Verma IC
    Indian J Med Res; 2011 Apr; 133(4):442-5. PubMed ID: 21537100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incontinentia pigmenti (Bloch-Sulzberger syndrome)].
    Mühlenstädt E; Eigelshoven S; Hoff NP; Reifenberger J; Homey B; Bruch-Gerharz D
    Hautarzt; 2010 Oct; 61(10):831-3. PubMed ID: 20865235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
    Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
    Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variable clinical expression of familial Incontinentia Pigmenti syndrome - presentation of three cases].
    Kutkowska-Kaźmierczak A; Obersztyn E; Bonnefont JP; Rosińska-Borkowska D; Mazurczak T; Sobczyńska-Tomaszewska A; Mazurczak T
    Med Wieku Rozwoj; 2008; 12(3):748-53. PubMed ID: 19305025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms.
    Fusco F; Paciolla M; Napolitano F; Pescatore A; D'Addario I; Bal E; Lioi MB; Smahi A; Miano MG; Ursini MV
    Hum Mol Genet; 2012 Mar; 21(6):1260-71. PubMed ID: 22121116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients.
    Fusco F; Fimiani G; Tadini G; Michele D; Ursini MV
    J Am Acad Dermatol; 2007 Feb; 56(2):264-7. PubMed ID: 17224368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).
    Aradhya S; Courtois G; Rajkovic A; Lewis RA; Levy M; Israël A; Nelson DL
    Am J Hum Genet; 2001 Mar; 68(3):765-71. PubMed ID: 11179023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.